01 1SMS Pharmaceuticals
01 1SUMATRIPTAN USP (ALTERNATIVE SYNTHESIS)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-13
Pay. Date : 2013-08-02
DMF Number : 20906
Submission : 2007-10-03
Status : Active
Type : II
20
Sms Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SUMATRIPTAN USP (ALTERNATIVE SYNTHESIS), with a corresponding US DMF Number 20906.
Remarkably, this DMF maintains an Active status since its submission on October 03, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 13, 2013, and payment made on August 02, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
